Loading data
RNACNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 400 k USD | 38.28 m USD | 26 m USD | 110.78 m USD | 85.08 m USD |
| Research and development expense | 58.03 m USD | 45.11 m USD | 71.26 m USD | 72.38 m USD | 68.74 m USD |
| Operating profit | -143.41 m USD | -43.9 m USD | -86.42 m USD | 14.54 m USD | -4.6 m USD |
| Interest expense | — | — | 2.83 m USD | 3.03 m USD | 2.84 m USD |
| Profit before tax | -139.5 m USD | -77.14 m USD | -238.71 m USD | 34.77 m USD | -9.72 m USD |
| Income tax expense | -9.19 m USD | 287 k USD | -19 m USD | -609 k USD | 15.97 m USD |
| Net income (reported basis) | -130.3 m USD | -77.42 m USD | -219.71 m USD | 35.38 m USD | -25.69 m USD |
| Net income attributable to common shareholders | -130.3 m USD | -77.42 m USD | -257.26 m USD | 35.38 m USD | -25.69 m USD |
| Basic earnings per share | -5.02 USD/share | -4.48 USD/share | -49.76 USD/share | 0.24 USD/share | -0.22 USD/share |
| Diluted earnings per share | -5.02 USD/share | -4.49 USD/share | -49.76 USD/share | 0.1 USD/share | -0.22 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.